GWO XI STEM CELL APPLIED TECH CO LTD has a total of 26 patent applications. It decreased the IP activity by 62.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, China and Malaysia. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are NEUROTECH USA INC, RIORDAN NEIL H and IDOGEN AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | China | 10 | |
#3 | Malaysia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Macromolecular chemistry and polymers | |
#6 | Foods and drinks | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Electrotherapy | |
#5 | Specific use of cosmetics | |
#6 | Object sterilising | |
#7 | Implantable devices | |
#8 | Foods | |
#9 | Compounding processes | |
#10 | Macromolecular compounds compositions |
# | Name | Total Patents |
---|---|---|
#1 | Lin Po-Cheng | 16 |
#2 | Harn Horng-Jyh | 13 |
#3 | Chuang Ming-Hsi | 12 |
#4 | Lin Shinn-Zong | 12 |
#5 | Chiou Tzyy-Wen | 7 |
#6 | Fu Ru-Huei | 5 |
#7 | Lin Yi-Chun | 5 |
#8 | Liu Shih-Ping | 5 |
#9 | Lee Chia-Hsin | 4 |
#10 | Chen Chun-Hung | 3 |
Publication | Filing date | Title |
---|---|---|
US2020188465A1 | Treatment of cytokine release syndrome by decreasing level of proinflammatory cytokine | |
US2017258841A1 | Pharmaceutical compositions for treating arrhythmia and therapeutics of | |
US2017087191A1 | Food supplement increase cd34+ stem cells and telomerase activity | |
CN105708858A | Preparation method of growth-factor-platelet-rich fibrin and releasate |